US News

FDA Review of Pfizer Covid-19 Vaccine for Kids Expected

U.S. health regulators are expected to weigh in soon on the evidence for giving the Pfizer-BioNTech Covid-19 vaccine to children 5 to 11 years old.

Jump To The Original Source

Facebook Comments

Check Also

In Low Key Move, Singapore’s Central Bank Adds 26 Tonnes To Its Gold Reserves

In Low Key Move, Singapore’s Central Bank Adds ...

Archives